Indexed keywords
ANTIGEN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
IMMUNOGLOBULIN A;
MARKER;
PNEUMOCOCCUS VACCINE;
VACCINE;
VARICELLA ZOSTER VACCINE;
ARTICLE;
CHICKENPOX;
CORRELATE OF PROTECTION;
ENZYME LINKED IMMUNOSORBENT ASSAY;
HERPES ZOSTER;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
IMMUNE RESPONSE;
IMMUNE SYSTEM;
IMMUNOLOGICAL PARAMETERS;
MECHANISTIC CORRELATE OF PROTECTION;
NOMENCLATURE;
NONMECHANISTIC CORRELATE OF PROTECTION;
PATHOGENESIS;
PNEUMOCOCCAL INFECTION;
PREDICTION;
PRIORITY JOURNAL;
VACCINATION;
ANIMALS;
BIOLOGICAL MARKERS;
DRUG EVALUATION;
HUMANS;
TERMINOLOGY AS TOPIC;
VACCINES;
1
38449106454
A framework for assessing immunological correlates of protection in vaccine trials
Qin L, Gilbert PB, Corey L, McElrath MJ, Self SG. A framework for assessing immunological correlates of protection in vaccine trials. J Infect Dis 2007; 196:1304-12.
(2007)
J Infect Dis , vol.196
, pp. 1304-1312
Qin, L.1
Gilbert, P.B.2
Corey, L.3
McElrath, M.J.4
Self, S.G.5
2
0035155744
Immunologic correlates of protection induced by vaccination
Plotkin SA. Immunologic correlates of protection induced by vaccination. Pediatr Infect Dis J 2001; 20:63-75.
(2001)
Pediatr Infect Dis J , vol.20
, pp. 63-75
Plotkin, S.A.1
3
47549116006
Vaccines: Correlates of vaccine-induced immunity
Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008; 47:401-9.
(2008)
Clin Infect Dis , vol.47
, pp. 401-409
Plotkin, S.A.1
4
77954357410
Correlates of protection induced by vaccination
Plotkin SA. Correlates of protection induced by vaccination. Clin Vaccine Immunol 2010; 17:1055-65.
(2010)
Clin Vaccine Immunol , vol.17
, pp. 1055-1065
Plotkin, S.A.1
5
0024520844
Surrogate endpoints in clinical trials: Definition and operational criteria
Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Stat Med 1989; 8:431-40.
(1989)
Stat Med , vol.8
, pp. 431-440
Prentice, R.L.1
6
33845484073
Augmented designs to assess immune response in vaccine trials
Follmann D. Augmented designs to assess immune response in vaccine trials. Biometrics 2006; 62:1161-9.
(2006)
Biometrics , vol.62
, pp. 1161-1169
Follmann, D.1
7
80053481117
Commentary on "principal stratification\a goal or a tool?" by Judea Pearl
Article 36
Gilbert PB, Hudgens MG, Wolfson J. Commentary on "Principal stratification\a goal or a tool?" by Judea Pearl. Int J Biost 2011; 7:Article 36.
(2011)
Int J Biost , vol.7
Gilbert, P.B.1
Hudgens, M.G.2
Wolfson, J.3
8
14844282302
Meningococcal surrogates of protection\serum bactericidal antibody activity
Borrow R, Balmer P, Miller E. Meningococcal surrogates of protection\serum bactericidal antibody activity. Vaccine 2005; 23:2222-7.
(2005)
Vaccine , vol.23
, pp. 2222-2227
Borrow, R.1
Balmer, P.2
Miller, E.3
9
70349331506
Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine
Weinberg A, Zhang JH, Oxman GR, et al. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine. J Infect Dis 2009; 200:1068-77.
(2009)
J Infect Dis , vol.200
, pp. 1068-1077
Weinberg, A.1
Zhang, J.H.2
Oxman, G.R.3
10
33644928718
Immunity and correlates of protection for rotavirus vaccines
Franco MA, Angel J, Greenberg HB. Immunity and correlates of protection for rotavirus vaccines. Vaccine 2006; 24:2718-31.
(2006)
Vaccine , vol.24
, pp. 2718-2731
Franco, M.A.1
Angel, J.2
Greenberg, H.B.3
